Se suponía que iba a ser más fácil. Cuando la Ley de Cuidado de Salud a Bajo Precio (ACA) se aprobó en marzo de 2010, el objetivo era ayudar a que más personas en el país obtuvieran seguro médico. Y, de hecho, la creación de mercados en línea y la ampliación de los criterios de…
In St. Louis, a team of students aboard a well-equipped van visits senior centers, a nursing home, a church, and other sites, learning to conduct comprehensive, hourlong geriatric assessments. The team — future doctors, social workers, psychologists, and therapists — looks for such common problems as frailty, muscle weakness, and cognitive decline. The patients they…
By MATTHEW HOLT It was not so long ago that you could create one of those maps of health care IT or digital health and be roughly right. I did it myself back in the Health 2.0 days, including the old sub categories of the “Rebel Alliance of New Provider Technologies” and the “Frontier of…
As we all work to wrap up the year and enter into 2025, here are a few trends to keep your eye on in the coming months and beyond. The post 2025 and Beyond: Key Trends to Watch in Pharmacy appeared first on MedCity News.
As legal and compliance professionals, we champion privacy and cybersecurity in our organizations — but success requires a team effort. The post The Evolving Landscape of Privacy and Cybersecurity: Essential Strategies for Legal and Compliance Professionals appeared first on MedCity News.
Months before the FTC sued the three largest pharmacy benefit managers, the CEO of Blue Shield of California battled its PBM – CVS Caremark – to bring a lower cost prostate cancer drug to its members. The post Video: Why the FTC’s Lawsuit Against PBMs May Have Some Legs appeared first on MedCity News.
By ARIEL FRISTOE As the artistic director of Out of Hand Theater, an arts organization that promotes anti-racism, social activism and health equity, I believe the recent appointment of Robert F. Kennedy, Jr. (RFK) as Secretary to the Department of Health and Human Services is beyond concerning. RFK is not a doctor, nor is he…
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions. The post FDA Wraps Up 2024 Handing Out Several Notable Regulatory Decisions appeared first on MedCity News.
SAN FRANCISCO — For years, Latinos represented the biggest share of new HIV cases in this city, but testing data suggests the tide may be turning. The number of Latinos newly testing positive for HIV dropped 46% from 2022 to 2023, according to a preliminary report released in July by the San Francisco Department of…
The number of US employees offered ICHRAs continues to grow. Yet, headwinds – including competition, individual coverage market uncertainty, and complexity – may hamper the ICHRA opportunity. The post So What’s the Deal with ICHRA? appeared first on MedCity News.